10-6044329-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000417.3(IL2RA):​c.64+17759C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.188 in 152,254 control chromosomes in the GnomAD database, including 3,104 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3104 hom., cov: 33)

Consequence

IL2RA
NM_000417.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.44

Publications

17 publications found
Variant links:
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Gene-Disease associations (from GenCC):
  • immunodeficiency due to CD25 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • type 1 diabetes mellitus 10
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000417.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
NM_000417.3
MANE Select
c.64+17759C>A
intron
N/ANP_000408.1
IL2RA
NM_001308242.2
c.64+17759C>A
intron
N/ANP_001295171.1
IL2RA
NM_001308243.2
c.64+17759C>A
intron
N/ANP_001295172.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL2RA
ENST00000379959.8
TSL:1 MANE Select
c.64+17759C>A
intron
N/AENSP00000369293.3
IL2RA
ENST00000379954.5
TSL:1
c.64+17759C>A
intron
N/AENSP00000369287.1
IL2RA
ENST00000447847.2
TSL:1
c.64+17759C>A
intron
N/AENSP00000402024.2

Frequencies

GnomAD3 genomes
AF:
0.188
AC:
28547
AN:
152136
Hom.:
3100
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.286
Gnomad AMR
AF:
0.147
Gnomad ASJ
AF:
0.139
Gnomad EAS
AF:
0.266
Gnomad SAS
AF:
0.234
Gnomad FIN
AF:
0.271
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.226
Gnomad OTH
AF:
0.181
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.188
AC:
28564
AN:
152254
Hom.:
3104
Cov.:
33
AF XY:
0.189
AC XY:
14094
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.106
AC:
4410
AN:
41548
American (AMR)
AF:
0.147
AC:
2252
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
483
AN:
3472
East Asian (EAS)
AF:
0.266
AC:
1377
AN:
5184
South Asian (SAS)
AF:
0.235
AC:
1135
AN:
4828
European-Finnish (FIN)
AF:
0.271
AC:
2872
AN:
10588
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.225
AC:
15338
AN:
68018
Other (OTH)
AF:
0.186
AC:
394
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1175
2349
3524
4698
5873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
314
628
942
1256
1570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.197
Hom.:
1923
Bravo
AF:
0.172
Asia WGS
AF:
0.274
AC:
953
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.099
DANN
Benign
0.51
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs942201; hg19: chr10-6086292; API